Lilly Endowment Form 144: Sell 295,000 LLY shares, $300,245,100
Lilly Endowment Inc. filed a Form 144 notice to sell 295,000 shares of Eli Lilly and Company (LLY) common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Lilly Endowment Inc. filed a Form 144 notice to sell 295,000 shares of Eli Lilly and Company (LLY) common stock. The filing lists an aggregate market value $300,245,100, an approximate sale date of November 13, 2025, execution through Fidelity Capital Markets, and trading on NYSE, NASDAQ.
The filing notes that 945,383,757 shares of Eli Lilly common stock are outstanding. The securities to be sold trace back to a gift acquired on 02/10/1948 from the J.K. Lilly Sr. Trust, with the donor’s acquisition dated 01/21/1937 and an original amount acquired of 38,400,000 shares.
Recent sales over the past three months are disclosed, including 305,000 shares for $308,411,211.50 on 11/12/2025 and 283,131 shares for $279,347,662.01 on 11/11/2025.
AI-generated analysis. How Rhea-AI works. Not financial advice.